CBPO - China Biologic Products Holdings, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Cash flows from operating activities
Net Income
147,168
128,056
67,943
104,779
89,043
Depreciation & amortization
24,009
23,225
12,909
12,738
9,034
Deferred income taxes
-1,900
-4,160
-3,253
-3,007
-170
Stock based compensation
16,076
23,131
33,903
24,406
12,114
Change in working capital
-58,407
-88,276
-23,355
-36,578
-28,621
Accounts receivable
-38,814
-53,880
-39,919
-10,972
-7,146
Inventory
-25,544
-42,594
-42,078
-40,077
-32,095
Accounts Payable
4,962
8,141
977
2,967
5,349
Other working capital
119,943
67,226
63,893
72,251
57,100
Other non-cash items
-
-
-
23,017
10,596
Net cash provided by operating activites
152,633
103,942
102,184
123,259
109,392
Cash flows from investing activities
Investments in property, plant and equipment
-32,689
-36,716
-38,291
-51,007
-52,292
Acquisitions, net
-
-
-
-
-
Purchases of investments
-3,473,085
-2,737,660
-22,669
-
-40,744
Sales/Maturities of investments
2,998,145
2,117,605
-
0
-
Other investing activites
-
-
-
-12,333
-38,291
Net cash used for investing activites
-507,521
-558,945
-60,895
-52,520
-89,756
Cash flows from financing activities
Debt repayment
-
0
-23,412
0
-113,501
Common stock issued
-
590,265
0
0
80,584
Common stock repurchased
-120,043
-10,000
-
0
-
Dividends Paid
-
-
-
-
-
Other financing activites
-
-10,145
-18,789
-25,643
60,980
Net cash used privided by (used for) financing activities
455,669
571,304
-18,324
-22,084
51,580
Net change in cash
99,152
119,544
35,571
38,828
64,118
Cash at beginning of period
103,299
219,337
183,766
144,938
80,820
Cash at end of period
204,081
338,881
219,337
183,766
144,938
Free Cash Flow
Operating Cash Flow
152,633
103,942
102,184
123,259
109,392
Capital Expenditure
-32,689
-36,716
-38,291
-51,007
-52,292
Free Cash Flow
119,943
67,226
63,893
72,251
57,100